InvestLog
ABCL logo

ABCL

AbCellera Biologics Inc.NASDAQHealthcare
$3.52+0.28%ClosedMarket Cap: $1.07B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-11-07Leerink Partners—Market Perform—
2025-08-08Stifel—Buy—
2025-07-14Keybanc—Overweight—
2025-05-16Truist Securities—Buy—
2025-05-09Stifel—Buy—
2025-04-16Keybanc—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.66$37.0M3
Sun Dec 31$-0.78$55.2M3
Mon Dec 31$-0.75$72.2M1
Tue Dec 31$-0.59$117.6M1